Driving Research

The IMF works collaboratively with leading myeloma experts to chart the course for a cure for multiple myeloma, to mentor the next generation of innovative investigators in the field, and to improve the lives of myeloma patients through better care. Since its creation of the first junior and senior grant program for myeloma researchers, to the founding of the International Myeloma Working Group and the implementation of the Black Swan Research Initiative®, the IMF has taken bold and innovative steps to move myeloma research forward.

Driving Research

  • Black Swan Research Initiative

    • Introducing the IMF’s Black Swan Research Initiative® Understanding that the search for a cure for multiple myeloma demands constant innovation, the IMF has launched the Black Swan Research Initiative®, a unique project to develop the first definitive cure for myeloma. Led by a multinational consortium of leading myeloma experts, we are bridging...

    • The International Myeloma Foundation recognizes donors who have made significant gifts to the Black Swan Research Initiative. With your help, we will soon bridge the gap from long-term remission to cure. We look forward to our continued partnership with our donors and encourage new donors to consider a gift at one of the following levels:...

  • International Myeloma Working Group

    • The International Myeloma Working Group (IMWG) was formed by the IMF to encourage dialog and collaboration among the world’s leading myeloma experts. IMWG members are divided into workgroups. Researchers in each group work together to examine such important topics as frontline therapy, continuous therapy, the role of transplant, genetic risk...

    • ​ The IMWG has a two-fold task: to conduct translational research—from lab bench to patient bedside—under the auspices of the IMF and to publish consensus statements and guidelines for the management of myeloma. These publications represent both the work of the IMWG and the work of individual IMWG members who have based their papers on IMWG data...

  • Asian Myeloma Network

    • The Asian Myeloma Network (AMN) was established by the International Myeloma Foundation (IMF) at a meeting in Singapore in 2011. The AMN is composed of myeloma experts from China, Hong Kong, Taiwan, Japan, South Korea, Singapore, and Thailand. The first of its kind in the region, the AMN is carrying out clinical trials and has taken the lead in...

    • Multiple myeloma (MM) is one of the most common hematologic malignancies, with 114,252 new cases and 80,119 deaths worldwide annually in 2012, comprising 0.8% and 1% of all cancers, respectively [1]. Its incidence is known to vary by ethnicity, with Asians showing a relatively lower incidence than Caucasians by IARC data as well as US SEER data...

  • Nurse Leadership Board

    • In 2006, the IMF founded the Nurse Leadership Board® as a professional partnership to rep­resent nurse experts caring for myeloma patients at leading medical centers. The NLB is improving the nurs­ing care and self-care of patients with myeloma via consensus publi­cations, symposia, multimedia, and research.  

    • Learn about the latest myeloma research. Get a front row seat at the most critical medical meetings. Watch Dr. Brian Durie, IMF Chairman, address issues that are important to the entire myeloma community. IMF TV brings it all to you.

  • Brian D Novis Research Grants

    • The grant application period will open in Spring 2017 In 1995, the IMF established the Brian D. Novis Research Grant program in memory of its co-founder. The grants are awarded annually to promote research into all areas of myeloma in an effort to improve patient outcomes. To date, the IMF has funded more than 100 of the most promising projects...

    • The International Myeloma Foundation funds several research grants including the Brian D. Novis Research Award. These grants are provided through donations from private individuals, and are presented annually by the International Myeloma Foundation. These awards go to researchers doing work in the field of multiple myeloma and related disorders...

  • Kyle Lifetime Achivement Award

    • Since 2003, the IMF has honored an outstanding physician each year with the Robert A. Kyle Lifetime Achievement Award. The award, named for its first recipient, is presented to an individual whose body of work in the field of myeloma has made significant advances in research, treatment and care of myeloma patients. Our honorees’ work reflects the...

    • The International Myeloma Foundation (IMF) — improving the quality of life of myeloma patients while working toward prevention and a cure —presented the 14th annual Robert A. Kyle Lifetime Achievement Award to Dr. S. Vincent Rajkumar during a ceremony in Copenhagen, Denmark on June 8, 2016. Since 2003, the IMF has honored an outstanding physician...